QT interval prolongation research hub

Study is designed to assess the safety and tolerability of ceralasertib at increasing doses in combination with other anti-cancer treatment in patients with advanced tumours

This study is testing a new cancer drug called ceralasertib. It's for people with advanced cancer and aims to see how safe it is and if it causes side effects when given with other cancer treatments. Researchers are looking at different doses to find the best way to use it.